Clinical Implications of Intestinal Barrier Damage in Psoriasis
Mariusz Sikora,1 Albert Stec,1 Magdalena Chrabaszcz,1 Joanna Giebultowicz,2 Emilia Samborowska,3 Radoslaw Jazwiec,3 Michal Dadlez,3,4 Malgorzata Olszewska,1 Lidia Rudnicka1 1Department of Dermatology, Medical University of Warsaw, Warsaw, Poland; 2Department of Bioanalysis and Drug Analysis, Faculty...
Guardado en:
Autores principales: | Sikora M, Stec A, Chrabaszcz M, Giebultowicz J, Samborowska E, Jazwiec R, Dadlez M, Olszewska M, Rudnicka L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/109e863ee3de4425bdf43dd67cbb8eb5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gut and Cutaneous Microbiome Featuring Abundance of Lactobacillus reuteri Protected Against Psoriasis-Like Inflammation in Mice
por: Chen HL, et al.
Publicado: (2021) -
Role of Goblet Cells in Intestinal Barrier and Mucosal Immunity
por: Yang S, et al.
Publicado: (2021) -
Restraint Stress in Hypertensive Rats Activates the Intestinal Macrophages and Reduces Intestinal Barrier Accompanied by Intestinal Flora Dysbiosis
por: Wang T, et al.
Publicado: (2021) -
Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19
por: Zou Y, et al.
Publicado: (2021) -
Overexpression of Lin28a Aggravates Psoriasis-Like Phenotype by Regulating the Proliferation and Differentiation of Keratinocytes
por: Jang S, et al.
Publicado: (2021)